Avlon, Bristol


Avlon is the manufacturing home of the Active Pharmaceutical Ingredients (APIs) for two of our key medicines.

Efficient production processes at Avlon are vitally important to our work, but we’ve also been focusing on minimising the environmental impact of our manufacturing.

In 2009, we implemented a new, industry-leading API recovery process at the site and in 2012 we installed a large solvent recovery unit. These improvements reduce aqueous incineration waste and solvent waste which has environmental benefits, as well as being a more cost effective form of production.

Avlon also has its own effluent treatment plant and the site generates most of its own heat and power through its own energy plant.

In the UK, we produce enough API to treat 18 million patients around the world every day.